# The Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity

> **NCT02814617** · PHASE2,PHASE3 · COMPLETED · sponsor: **Chonbuk National University Hospital** · enrollment: 80 (actual)

## Conditions studied

- Immunity

## Interventions

- **DIETARY_SUPPLEMENT:** Cordyceps sinensis mycelium culture extract 1.68 g
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02814617
- **Lead sponsor:** Chonbuk National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2015-09
- **Final completion:** 2015-11
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2016-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02814617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02814617, "The Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02814617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*